Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Reinforcing commitment to ethical and sustainable growth
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Subscribe To Our Newsletter & Stay Updated